Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Apple
AAPL
|
+$704M |
| 3 |
Amazon
AMZN
|
+$670M |
| 4 |
Merck
MRK
|
+$431M |
| 5 |
NVIDIA
NVDA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
JD.com
JD
|
+$196M |
| 3 |
Aon
AON
|
+$184M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FATBB
3701
DELISTED
FAT Brands
FATBB
| $1.04M | ﹤0.01% |
+122,276
| New | +$943K |
|
3702
GH Research
GHRS
$1.93B
| $1.04M | ﹤0.01% |
44,633
+17,435
| +64% | +$383K |
|
3703
ORIX
IX
$43.7B
| $1.04M | ﹤0.01% |
50,985
-2,005
| -4% | -$39.9K |
|
3704
Immunome
IMNM
$2.61B
| $1.04M | ﹤0.01% |
79,968
+25,299
| +46% | +$451K |
|
3705
Rani Therapeutics
RANI
$90.1M
| $1.03M | ﹤0.01% |
63,217
+41,578
| +192% | +$945K |
|
3706
Schwab International Equity ETF
SCHF
$67.1B
| – | – |
0
| – | – |
|
3707
Union Bankshares
UNB
$109M
| $1.03M | ﹤0.01% |
35,546
| – | – |
|
|
AUTL
3708
Autolus Therapeutics
AUTL
$484M
| $1.03M | ﹤0.01% |
198,485
+135,956
| +217% | +$816K |
|
3709
inTEST
INTT
$167M
| $1.03M | ﹤0.01% |
80,880
| – | – |
|
|
OMCC
3710
DELISTED
Old Market Capital Corp
OMCC
| $1.03M | ﹤0.01% |
87,190
-300
| -0.3% | -$3.56K |
|
3711
Acme United Corp
ACU
$220M
| $1.02M | ﹤0.01% |
30,430
| – | – |
|
|
ZYNE
3712
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.02M | ﹤0.01% |
355,509
+5,737
| +2% | +$21.2K |
|
|
MGIC
3713
DELISTED
Magic Software Enterprises
MGIC
| $1.02M | ﹤0.01% |
48,749
+484
| +1% | +$10.5K |
|
|
OKUR
3714
OnKure Therapeutics
OKUR
$162M
| $1.02M | ﹤0.01% |
11,924
-143
| -1% | -$10.5K |
|
3715
Kaltura
KLTR
$208M
| $1.02M | ﹤0.01% |
302,345
+57,598
| +24% | +$382K |
|
|
HUT
3716
Hut 8
HUT
$12.6B
| $1.01M | ﹤0.01% |
25,779
+2,913
| +13% | +$164K |
|
3717
NRX Pharmaceuticals
NRXP
$139M
| $1.01M | ﹤0.01% |
21,150
+16,573
| +362% | +$1.2M |
|
3718
Surrozen
SRZN
$253M
| $1.01M | ﹤0.01% |
10,448
+1,879
| +22% | +$213K |
|
3719
Actinium Pharmaceuticals
ATNM
$25.5M
| $1M | ﹤0.01% |
167,172
| – | – |
|
|
CGAU
3720
Centerra Gold
CGAU
$3.44B
| $1M | ﹤0.01% |
115,138
+26,228
| +29% | +$199K |
|
3721
Orion Group Holdings
ORN
$405M
| $1M | ﹤0.01% |
265,703
-1,016
| -0.4% | -$4.52K |
|
3722
Graham Corp
GHM
$1.16B
| $999K | ﹤0.01% |
80,361
| – | – |
|
|
SUP
3723
DELISTED
Superior Industries International
SUP
| $996K | ﹤0.01% |
222,530
+4,684
| +2% | +$24.7K |
|
3724
Plumas Bancorp
PLBC
$428M
| $995K | ﹤0.01% |
29,460
| – | – |
|
3725
Genie Energy
GNE
$373M
| $993K | ﹤0.01% |
178,450
| – | – |
|
Similar funds
Geode Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Geode Capital Management held 5,071 positions worth $830B, up 12% from $743B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q4 2021 filing shows 216 new, 2,976 increased, 1,070 reduced and 95 closed positions. Its largest new stake was Rivian: 2,078,098 shares worth $215M. The largest sale was Kansas City Southern, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2021 buy was Rivian: 2,078,098 shares worth $215M.
- Geode Capital Management added most to Microsoft in Q4 2021, an estimated $981M increase.
- Geode Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $196M.
- Geode Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $441M.
- Geode Capital Management's ten largest holdings make up 24% of its $830B portfolio in Q4 2021.
- Geode Capital Management opened 216 new positions and closed 95 in Q4 2021.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $830B.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.